Clinical Trials Directory

Trials / Completed

CompletedNCT04432467

Fertility Restoration Using Autologous Mesenchymal Stem Cells

Fertility Restoration Using Autologous Adipose Tissue Derived Mesenchymal Stem Cells

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Treatment of the patients with scarring and adhesions in the uterus resulting from caesarean section or chronic inflammation in the mucosa of the uterus and fallopian tubes and preventing the occurrence of these effects in the future

Detailed description

The aim of the project is to develop a biomedical cell product based on autologous adipose tissue derived mesenchymal stem cells and a biodegradable carrier for highly effective treatment and prevention of scarring and adhesions in the uterus acquired as a result of cesarean section or chronic inflammatory processes in the uterine mucosa and fallopian tubes; to conduct the clinical trials of the biomedical cell product in the treatment of uterus scarring and infertility in women.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous mesenchymal stem cellsAutologous adipose tissue-derived mesenchymal stem cells
OTHERstandard treatmentstandard treatment according to clinical protocols

Timeline

Start date
2020-10-01
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2020-06-16
Last updated
2021-12-10

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT04432467. Inclusion in this directory is not an endorsement.